🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications

Yuxin Lin, Jianxin Xu et al. (2019)

Journal of Hematology & Oncology

1.3K citesjournal articlePDF

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E. Senkus, S. Kyriakides et al. (2015)

Annals of Oncology

1.3K citesjournal articlePDF

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Yuankai Shi, Joseph Siu-Kie Au et al. (2014)

Journal of Thoracic Oncology

1.3K citesjournal articlePDF

Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer

Sahar M.A. Mahmoud, Emma Claire Paish et al. (2011)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond et al. (2007)

Archives of Pathology & Laboratory Medicine

1.2K citesjournal articlePDF

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

P. Feugier, A. Van Hoof et al. (2005)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Mitchell Machtay, Jennifer Moughan et al. (2008)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study

Masaaki Yamamoto, Toru Serizawa et al. (2014)

The Lancet Oncology

1.2K citesjournal articlePDF

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

David A. Eberhard, Bruce E. Johnson et al. (2005)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

Martin Reck, Joachim von Pawel et al. (2009)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Breast cancer in China

Lei Fan, Kathrin Strasser-Weippl et al. (2014)

The Lancet Oncology

1.2K citesjournal articlePDF

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

J. Naidoo, D.B. Page et al. (2015)

Annals of Oncology

1.2K citesjournal articlePDF

Long-term outcomes following CAR T cell therapy: what we know so far

Kathryn M. Cappell, James N. Kochenderfer (2023)

Nature Reviews Clinical Oncology

1.4K citesjournal articlePDF

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer

Nancy L. Keating, A. James O'Malley et al. (2006)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

David R. Spigel, Corinne Faivre-Finn et al. (2022)

Journal of Clinical Oncology

1.4K citesjournal articlePDF